Journal of Neuroimmunology
Volume 220, Issue 1 , Pages 79-89 , 30 March 2010

Chronic restraint stress during early Theiler's virus infection exacerbates the subsequent demyelinating disease in SJL mice: II. CNS disease severity

  • Erin E. Young

      Affiliations

    • Department of Psychology, College of Liberal Arts, Texas A&M University College Station, TX 77843, United States
    • Corresponding Author InformationCorresponding author. Department of Psychology, Texas A&M University, Mailstop 4235, College Station, TX 77843-4235, United States. Tel.: +1 979 458 1312; fax: +1 979 845 4727.
  • ,
  • Amy N. Sieve

      Affiliations

    • Department of Psychology, College of Liberal Arts, Texas A&M University College Station, TX 77843, United States
  • ,
  • Elisabeth G. Vichaya

      Affiliations

    • Department of Psychology, College of Liberal Arts, Texas A&M University College Station, TX 77843, United States
  • ,
  • Luis M. Carcoba

      Affiliations

    • Department of Psychology, College of Liberal Arts, Texas A&M University College Station, TX 77843, United States
  • ,
  • Colin R. Young

      Affiliations

    • Department of Veterinary Integrative Biosciences, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University College Station, TX 77843, United States
  • ,
  • Andrew Ambrus

      Affiliations

    • Department of Veterinary Pathobiology, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University College Station, TX 77843, United States
  • ,
  • Ralph Storts

      Affiliations

    • Department of Veterinary Pathobiology, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University College Station, TX 77843, United States
  • ,
  • C. Jane R. Welsh

      Affiliations

    • Department of Veterinary Integrative Biosciences, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University College Station, TX 77843, United States
    • Department of Veterinary Pathobiology, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University College Station, TX 77843, United States
  • ,
  • Mary W. Meagher

      Affiliations

    • Department of Psychology, College of Liberal Arts, Texas A&M University College Station, TX 77843, United States

Received 16 July 2009 ,Revised 22 January 2010 ,Accepted 22 January 2010.

References 

  1. Acheson ED. Epidemiology of multiple sclerosis. Br. Med. Bull. 1977;33:9–14
  2. Ackerman KD, Heyman R, Rabin BS, Anderson BP, Houck PR, Frank E, et al. Stressful life events precede exacerbations of multiple sclerosis. Psychosom. Med. 2002;64:916–920
  3. Ackerman KD, Stover A, Heyman R, Anderson BP, Houck PR, Frank E, et al. Relationship of cardiovascular reactivity, stressful life events, and multiple sclerosis disease activity. Brain Behav. Immun. 2003;17:141–151
  4. Alley J, Khasabov S, Simone D, Beitz A, Rodriguez M, Njenja MK. More severe neurological deficits in SJL/J male than female mice following Theiler's virus-induced CNS demyelination. Exp. Neurol. 2003;180:14–24
  5. Araneo BA, Dowell T, Diegel M, Daynes RA. Dihydrotestosterone exerts a depressive influence on the production of interleukin-4 (IL-4), IL-5, and gamma-interferon, but not IL-2 by activated murine T cells. Blood. 1991;78(3):688–699
  6. Aubagnac S, Brahic M, Bureau JF. Viral load and a locus on chromosome 11 affect the late clinical disease caused by Theiler's virus. J. Virol. 1999;73:7965–7971
  7. Blakemore WF, Welsh CJR, Tonks P, Nash AA. Observations on demyelinating lesions induced by Theiler's virus in CBA mice. Acta Neuropathol. 1988;76:581–589
  8. Borrow P, Tonks P, Welsh CJR, Nash AA. The role of CD8+ T cells in the acute and chronic phases of Theiler's virus-induced disease in mice. J. Gen. Virol. 1992;73:1861–1865
  9. Borrow P, Welsh CJR, Tonks P, Dean D, Blakemore WF, Nash AA. Investigation of the role of delayed-type-hypersensitivity responses to myelin in the pathogenesis of Theiler's virus-induced demyelinating disease. Immunology. 1998;93:478–484
  10. Brahic M, Bureau JF. Genetics of susceptibility to Theiler's virus infection. Bioessays. 1998;20(8):627–633
  11. Brahic M, Stroop WG, Baringer JR. Theiler's virus persists in glial cells during demyelinating disease. Cell. 1981;26(1):123–128
  12. Brahic M, Bureau JF, Michiels T. The genetics of the persistent infection and demyelinating disease caused by Theiler's virus. Ann. Rev. Microbiol. 2005;59:279–298
  13. Brown RF, Tennant CC, Sharrock M, Hodgkinson S, Dunn SM, Pollard JD. Relationship between stress and relapse in multiple sclerosis: part I. Important features. Mult. Scler. 2006;12:453–464
  14. Brown RF, Tennant CC, Sharrock M, Hodgkinson S, Dunn SM, Pollard JD. Relationship between stress and relapse in multiple sclerosis: part II. Direct and indirect relationships. Mult. Scler. 2006;12:465–475
  15. Buljevac D, Hop WCJ, Reedeker W, Janssens CJW, van der Meche FGA, van Doorn PA, et al. Self reported stressful life events and exacerbations in multiple sclerosis: prospective study. Br. Med. J. 2003;327:646–651
  16. Campbell T, Meagher MW, Sieve A, Scott B, Storts R, Welsh TH, et al. The effects of restraint on the neuropathogenesis of Theiler's virus infection: I. Acute disease. Brain Behav. Immun. 2001;15:235–254
  17. Challoner PB, Smith KT, Parker JD, MacLeod DL, Coulter SN, Rose TM, et al. Plaque-associated expression of human herpes virus 6 in multiple sclerosis. PNAS. 1995;92(16):7440–7444
  18. Clatch RJ, Lipton HL, Miller SD. Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease: II. Survey of host immune responses and central nervous system virus titres in inbred mouse strains. Microbiol. Pathol. 1987;3:327–337
  19. Cottrell DA, Kremenchutzky M, Rice GPA, Hader W, Baskerville J, Ebers GC. The natural history of multiple sclerosis: a geographically based study. Brain. 1999;122(4):641–647
  20. Dyment DA, Ebers GC, Sadovnick AD. Genetics of multiple sclerosis. Lancet Neurol. 2004;3:104–110
  21. Fazakerley JK, Walker R. Virus demyelination. J. Neurovirol. 2003;9(2):148–164
  22. Friedman A, Lorch Y. Theiler's virus infection: a model for multiple sclerosis. Prog. Med. Virol. 1985;31:43–83
  23. Fuller AC, Kang B, Kang HK, Yahikozowa H, Dal Canto MC, Kim BS. Gender bias in Theiler's virus-induced demyelinating disease correlates with the level of antiviral immune responses. J. Immunol. 2005;175:3955–3963
  24. Fuller A, Yahikozawa H, So EY, Dal Canto M, Koh CS, Welsh CJR, et al. Castration of male C57L/J mice increases susceptibility and estrogen treatment restores resistance to Theiler's virus-induced demyelinating disease. J. Neurosci. Res. 2007;85:871–881
  25. Gaillard RC, Spinedi E. Sex- and stress-steroids interactions and the immune system: evidence for a neuroendocrine-immunological sexual dimorphism. Domest. Anim. Endocrinol. 1998;15:345–352
  26. Gilden DH. Infectious causes of multiple sclerosis. Lancet Neurol. 2005;4:195–202
  27. Gottlieb S. Epstein–Barr virus may increase risk of multiple sclerosis. BMJ. 2003;326(7392):731
  28. Grant I, Brown GW, Harris T, McDonald WI, Patterson T, Trimble MR. Severely threatening events and marked life difficulties preceding onset or exacerbation of multiple sclerosis. J. Neurol. Neurosurg. Psychiatry. 1989;52:8–13
  29. Hill KE, Pigmans M, Fujinama RS, Rose JW. Theiler's virus induced demyelinating disease: differential susceptibility and effects of IL-4, IL-10, and combined IL-4 with IL-10. J. Neuroimmunol. 1998;85:44–51
  30. Holmes W. Silver staining of nerve axons. In: Recent Advances in Clinical Pathology. London: J. and A. Churchill Ltd; 1947;
  31. Homo-Delarche F, Fitzpatrick F, Christeff N, Nunez EA, Bach JF, Dardenne M. Sex steroids, glucocorticoids, stress, and autoimmunity. J. Steroid Biochem. Mol. Biol. 1991;40:619–637
  32. Huygen K, Palfliet K. Strain variation in interferon gamma production of BCG-sensitized mice challenged with PPD II. Importance of one major autosomal locus and additional sexual influences. Cell. Immunol. 1984;85(1):75–81
  33. Jacobson S, Fierlage ML, MacFarland HF. Impaired measles virus specific cytotoxic-T cell responses in multiple sclerosis. J. Exp. Med. 1985;162:839–850
  34. Johnson RR, Storts R, Welsh TH, Welsh CJR, Meagher MW. Social stress alters the severity of acute Theiler's virus infection. J. Neuroimmunol. 2004;148:74–85
  35. Johnson RR, Prentice TW, Bridegam P, Young CR, Steelman AJ, Welsh TH, et al. Social stress alters the severity and onset of the chronic phase of Theiler's virus infection. J. Neuroimmunol. 2006;175:39–51
  36. Kappel CA, Melvold RW, Kim BS. Influence of sex on susceptibility in the Theiler's murine encephalomyelitis virus model of multiple sclerosis. J. Neuroimmunol. 1990;29:15–19
  37. Kurtzke JF, Hyllestad K. MS epidemiology in the Faroe Islands. Rev. Neurol. 1987;57:77–87
  38. Lipton HL. Theiler's virus infection in mice: an unusual biphasic disease process leading to demyelination. Infect. Immun. 1975;11:1147–1155
  39. Lipton HL, Dal Canto MC. Contrasting effects of immunosuppression on Theiler's virus infection in mice. Infect. Immun. 1977;15(3):903–909
  40. Lipton HL, Melvold R. Genetic analysis of susceptibility to Theiler's virus-induced demyelinating disease in mice. J. Immunol. 1984;132:1821–1825
  41. Lyden DC, Olszewski J, Feran M, Job LP, Huber SA. Coxsackie virus B-3-induced myocarditis. Effect of sex steroids on viremia and infectivity of cardiocytes. Am. J. Pathol. 1987;126(3):432–438
  42. Martyn CN, Cruddas M, Compston DA. Symptomatic Epstein–Barr virus infection and multiple sclerosis. J. Neurol Neurosurg Psychiatry. 1993;56:167–168
  43. Meagher MW, Johnson RR, Young EE, Vichaya EG, Lunt S, Hardin EA, et al. Interleukin-6 as a mechanism for the adverse effects of social stress on acute Theiler's virus infection. Brain Behav. Immun. 2007;21(8):1083–1095
  44. Meagher, M.W., Sieve, A.N., Johnson, R.R., Satterlee, D., Belyavskyi, M., Mi, W., Prentice, T.W., Welsh Jr, T.H., Welsh, C.J.R., in press. Neonatal maternal separation alters immune, endocrine, and behavioral responses to acute Theiler's virus infection in adult mice. Behav Gen. doi:10.1007/s10519-010-9333-5.
  45. Mi W, Belyavskyi M, Johnson RR, Sieve AN, Storts R, Meagher MW, et al. Alterations in chemokine expression following Theiler's virus infection and restraint stress. J. Neuroimmunol. 2004;151:103–115
  46. Mi W, Prentice TW, Young CR, Johnson RR, Sieve AN, Meagher MW, et al. Restraint stress decreases virus-induced pro-inflammatory cytokine mRNA expression during acute Theiler's virus infection. J. Neuroimmunol. 2006;178(1–2):49–61
  47. Mi W, Young CR, Storts R, Steelman A, Meagher MW, Welsh CJR. Stress alters pathogenicity and facilitates systemic dissemination of Theiler's virus. Microb. Pathog. 2006;41:133–143
  48. Miller SD, Vanderlugt CL, Begolka WS, Pao W, Yauch RL, Neville KL, et al. Persistent infection with Theiler's virus leads to CNS autoimmunity via epitope spreading. Nat. Med. 1997;3:1133–1136
  49. Mohr DC, Cox D. Multiple sclerosis: empirical literature for the clinical health psychologist. J. Clin. Psych. 2001;57:479–499
  50. Mohr DC, Dick LP. Multiple sclerosis. In:  Camic PM,  Knight S editor. Clinical Handbook of Health Psychology: a Practical Guide to Effective Interventions. Seattle: Hogrefe and Huber; 1998;p. 313–348
  51. Mohr DC, Goodkin DE, Bacchetti P, Boudewyn AC, Huang L, Marrietta P, et al. Psychological stress and the subsequent appearance of new brain MRI lesions in MS. Psychosom. Med. 2000;64(5):803–809
  52. Njenga MK, Asakura K, Hunter SF, Wettstein P, Pease LR, Rodriguez M. The immune system preferentially clears Theiler's virus from the gray matter of the central nervous system. J. Virol. 1997;71(11):8592–8601
  53. Noseworthy JH, Licchinetti C, Rodriguez M, Weinshenker BG. Multiple sclerosis. N. Engl. J. Med. 2000;343:938–952
  54. Oleszak EL, Chang JR, Friedman H, Katsetos CD, Platsoucas CD. Theiler's virus infection: a model for multiple sclerosis. Clin. Microgiol. Rev. 2004;17(1):174–207
  55. Peña Rossi C, Delcroix M, Huitinga I, McAllister A, Van Rooijen N, Claassen E, et al. Role of macrophages in Theiler's virus infection. J. Virol. 1997;71:3336–3340
  56. Pozner RG, Berria MI, Negrotto S, Schattner M, Gomez RM. Differential astrocyte response to Theiler's murine encephalomyelitis virus infection. Intervirology. 2004;48:279–284
  57. Quinn DG, Zajac AJ, Frelinger JA, Muller D. Transfer of lymphocytic choriomeningitis disease in b2 microglobulin-deficient mice by CD4+ T cells. Int. Immunol. 1993;5(10):1193–1198
  58. Rodriguez M, Sriram S. Successful therapy of Theiler's virus-induced demyelination (DA strain) with monoclonal anti-Lyt2 antibody. J. Immunol. 1988;140:2950–2955
  59. Rodriguez M, Leibowitz JL, lampert PW. Persistent infeciton of oligodendrocytes in Theiler's virus-induced encephalomyelitis. Ann. Neurol. 1983;13:426–433
  60. Rodriguez M, Pavelko KD, Njenga MK, Logan WC, Wettstein PJ. The balance between persistent virus infection and immune cells determines demyelination. J. Immunol. 1996;157:5699–5709
  61. Roos RP, Wollman R. DA strain of Theiler's murine encephalomyelitis virus induces demyelination in nude mice. Ann. Neurol. 1988;15(5):494–499
  62. Rubio N, Sanz-Rodriguez F, Lipton HL. Theiler's virus induces the MIP-2 chemokine (CXCL2) in astrocytes from genetically susceptible but not from resistant mouse strains. Cell. Immunol. 2006;239:31–40
  63. Sheehan DC, Hrapchack BB. Theory and Practice of Histotechnology. 2nd ed. Columbus, OH: Battelle Press; 1987;169–175
  64. Sheridan JF, Dobbs C, Jung J, Chu X, Konstantinos A, Padgett D, et al. Stress-induced neuroendocrine modulation of viral pathogenesis and immunity. Ann. N.Y. Acad. Sci. 1991;840:803–808
  65. Sibley WA, Bamford CR, Clark K. Clinical viral infections and multiple sclerosis. Lancet. 1985;1(8441):1313–1315
  66. Sieve AN, Steelman AJ, Young CR, Storts R, Welsh TH, Welsh CJR, et al. Chronic restraint stress during early Theiler's virus infection exacerbates the subsequent demyelinating disease in SJL mice. J. Neuroimmunol. 2004;155:103–118
  67. Sieve AN, Steelman AJ, Young CR, Storts R, Welsh TH, Welsh CJR, et al. Sex dependent effects of chronic restraint stress during early Theiler's virus infection on the subsequent demyelinating disease in CBA mice. J. Neuroimmunol. 2006;177:46–62
  68. Sospedra M, Martin R. Immunology of multiple sclerosis. Annu. Rev. Immunol. 2005;23:683–747
  69. Steelman AJ, Dean DD, Young CR, Smith R, Prentice TW, Meagher MW, et al. Restraint stress modulates virus specific adaptive immunity during acute Theiler's virus infection. Brain Behav. Immun. 2009;23:830–843
  70. Stinissen P, Rau J, Zhang J. Autoimmune pathogenesis of multiple sclerosis: role of autoreactive T lymphocytes and new immunotherapeutic strategies. Crit. Rev. Immunol. 1997;17:33–75
  71. Turner BB. Sex difference in glucocorticoid binding in rat pituitary is estrogen dependent. Life Sci. 1990;46:1399–1406
  72. Warren S, Greenhill S, Warren KG. Emotional stress and the development of multiple sclerosis: case–control evidence of a relationship. J. Chronic Dis. 1982;35:821–831
  73. Weil A. A rapid method for staining myelin sheaths. Arch. Neurol. Psychiatry. 1928;20:392–393
  74. Welsh CJR, Tonks P, nash AA,, Blakemore WF. The effect of L3T4 cell depletion on the pathogenesis of Theiler's murine encephalomyelitis virus infection in CBA mice. J. Gen. Virol. 1987;68:1659–1667
  75. Welsh CJR, Bustamante L, Nayak M, Welsh TH, Dean DD, Meagher MW. The effects of restraint stress on the neuropathogenesis of Theiler's virus infection II: NK cell function and cytokine levels in acute disease. Brain Behav. Immun. 2004;18:166–174
  76. Whitacre CC, Reingold SC, O'Looney PA. A gender gap in autoimmunity. Science. 1999;283:1277–1279
  77. Young EE, Prentice TW, Satterlee D, McCullough H, Sieve AN, Johnson RR, et al. Glucocorticoid exposure alters the pathogenesis of Theiler's murine encephalomyelitis virus during acute infection. Physiol. Behav. 2008;95:63–71
  78. Zheng L, Calenoff MA, Dal Canto MC. Astrocytes, not microglia, are the main cells responsible for viral persistence in Theiler's murine encephalomyelitis virus infection leading to demyelination. J Neuroimmunol. 2001;118:256–267

PII: S0165-5728(10)00036-6

doi: 10.1016/j.jneuroim.2010.01.015

Journal of Neuroimmunology
Volume 220, Issue 1 , Pages 79-89 , 30 March 2010